CLICK HERE for the meeting brief.
CLICK HERE for the meeting agenda.
CLICK HERE for a list of the meeting attendees.

Meeting Objectives:

• Report evidence gathered on:
  • Critical tasks associated with clinical investigators’ conduct of clinical trials.
  • Gaps and redundancies in training for preparing clinical investigators to conduct clinical trials.
  • Suggested knowledge and skills necessary for the quality conduct of clinical trials.
• Evaluate proposed framework of characteristics within control of clinical investigator sites that define the quality conduct of a clinical trial.
• Discuss how preparing clinical investigators for the quality conduct of a clinical trial could be optimized.
• Identify the recommendations and tools that sponsors and investigators could implement to better prepare clinical investigators for the quality conduct of a clinical trial. Also, pinpoint the barriers—and solutions—to implementing these recommendations.

Meeting Presentations:

1. Welcome and Review of Aligned CTTI Work by Annemarie Forrest
2. The CTTI Investigator Qualification Project and Meeting Goals by Jennifer Goldsack
3. A Changing Ecosystem – A Brief Review of ICH GCP Renovations Planned and Currently Under Way by Theresa Mullin
4. Proposed Framework of Characteristics that Define the Quality Conduct of a Clinical Trial by Janette Panhuis
5. Evidence Gathering: Our Approach to Data Collection by Teri Swezey
6. Critical Tasks that our Evidence Suggests Should be Well Executed to Drive the Quality Conduct of a Clinical Trial by David Ciavarella
7. Perceived Risks to the Quality Conduct of Clinical Trials by Kate Haratonik
8. Knowledge and Skills our Evidence Suggests may be Needed to Perform Critical Tasks and Mitigate Risks to Quality Trial Conduct by Catherine Dillion
9. Evaluating Current Approaches to Preparing Investigators and Their Delegates by Patricia Hurley
10. Building a Learning Ecosystem by Tina Chuck
11. Case Study of an Investigator Mentoring Program by Emily Lemons
12. Delivering Effective Training to Investigators and Their Delegates by Tina Chuck
13. An Investigator's Reflections on Training by Christine Hildebrand
14. FDA's Perspective on GCP Training by Bridget Foltz